NASDAQ:RTRX - Retrophin News Headlines

$19.20
-0.17 (-0.88 %)
(As of 06/16/2019 04:00 PM ET)
Today's Range
$18.99
Now: $19.20
$19.42
50-Day Range
$17.79
MA: $18.84
$19.72
52-Week Range
$17.53
Now: $19.20
$33.00
Volume249,063 shs
Average Volume340,849 shs
Market Capitalization$795.65 million
P/E RatioN/A
Dividend YieldN/A
Beta0.89

Headlines

Retrophin (NASDAQ RTRX) News Headlines

Source:
DateHeadline
Retrophin Inc (NASDAQ:RTRX) Receives Consensus Rating of "Hold" from AnalystsRetrophin Inc (NASDAQ:RTRX) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - June 12 at 2:13 AM
Head-To-Head Survey: Retrophin (RTRX) vs. Merck KGaA (MKGAF)Head-To-Head Survey: Retrophin (RTRX) vs. Merck KGaA (MKGAF)
www.americanbankingnews.com - June 5 at 10:21 PM
Is Retrophin, Inc.'s (NASDAQ:RTRX) Balance Sheet A Threat To Its Future?Is Retrophin, Inc.'s (NASDAQ:RTRX) Balance Sheet A Threat To Its Future?
finance.yahoo.com - June 3 at 6:24 PM
Pharma bro Martin Shkreli sues Retrophin directors, ex-general counsel for more than $30 million from prison in Pennsylvania'Pharma bro' Martin Shkreli sues Retrophin directors, ex-general counsel for more than $30 million from prison in Pennsylvania
finance.yahoo.com - May 31 at 6:28 PM
From prison, Pharma Bro Martin Shkreli sues ex-colleagues for $30 millionFrom prison, 'Pharma Bro' Martin Shkreli sues ex-colleagues for $30 million
finance.yahoo.com - May 31 at 6:28 PM
Retrophin to Present at Upcoming Investor Conferences - Yahoo FinanceRetrophin to Present at Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - May 30 at 6:13 PM
Retrophin Inc (RTRX) Expected to Post Quarterly Sales of $42.66 MillionRetrophin Inc (RTRX) Expected to Post Quarterly Sales of $42.66 Million
www.americanbankingnews.com - May 29 at 1:06 AM
-$0.39 EPS Expected for Retrophin Inc (RTRX) This Quarter-$0.39 EPS Expected for Retrophin Inc (RTRX) This Quarter
www.americanbankingnews.com - May 28 at 12:15 AM
Retrophin Appoints Sandra E. Poole to Board of Directors - Yahoo FinanceRetrophin Appoints Sandra E. Poole to Board of Directors - Yahoo Finance
finance.yahoo.com - May 13 at 8:57 AM
Retrophin (RTRX) Adds Sandra E. Poole to Board - StreetInsider.comRetrophin (RTRX) Adds Sandra E. Poole to Board - StreetInsider.com
www.streetinsider.com - May 13 at 8:57 AM
Retrophin Appoints Sandra E. Poole to Board of DirectorsRetrophin Appoints Sandra E. Poole to Board of Directors
finance.yahoo.com - May 13 at 8:57 AM
Retrophin (RTRX) Q1 2019 Earnings Call Transcript - Motley FoolRetrophin (RTRX) Q1 2019 Earnings Call Transcript - Motley Fool
www.fool.com - May 10 at 8:59 AM
Retrophin (RTRX) Q1 2019 Earnings Call Transcript - Yahoo FinanceRetrophin (RTRX) Q1 2019 Earnings Call Transcript - Yahoo Finance
finance.yahoo.com - May 8 at 7:11 PM
Retrophin (RTRX) Q1 2019 Earnings Call TranscriptRetrophin (RTRX) Q1 2019 Earnings Call Transcript
finance.yahoo.com - May 8 at 7:11 PM
Retrophin (RTRX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo FinanceRetrophin (RTRX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
finance.yahoo.com - May 8 at 8:56 AM
Retrophin, Inc. (RTRX) CEO Eric Dube on Q1 2019 Results - Earnings Call Transcript - Seeking AlphaRetrophin, Inc. (RTRX) CEO Eric Dube on Q1 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 8 at 8:56 AM
Retrophin (RTRX) Reports Q1 Loss, Misses Revenue EstimatesRetrophin (RTRX) Reports Q1 Loss, Misses Revenue Estimates
finance.yahoo.com - May 8 at 8:56 AM
Edited Transcript of RTRX earnings conference call or presentation 7-May-19 8:30pm GMTEdited Transcript of RTRX earnings conference call or presentation 7-May-19 8:30pm GMT
finance.yahoo.com - May 8 at 8:56 AM
Retrophin misses by $0.27, misses on revenue - Seeking AlphaRetrophin misses by $0.27, misses on revenue - Seeking Alpha
seekingalpha.com - May 7 at 6:33 PM
Retrophin, Inc. to Host Earnings Call - Yahoo FinanceRetrophin, Inc. to Host Earnings Call - Yahoo Finance
finance.yahoo.com - May 7 at 6:33 PM
Here’s What Hedge Funds Think About Retrophin Inc (RTRX) - Yahoo FinanceHere’s What Hedge Funds Think About Retrophin Inc (RTRX) - Yahoo Finance
finance.yahoo.com - May 7 at 6:33 PM
Retrophin (RTRX) Misses Q1 EPS by 6c, Revenues Miss - StreetInsider.comRetrophin (RTRX) Misses Q1 EPS by 6c, Revenues Miss - StreetInsider.com
www.streetinsider.com - May 7 at 6:33 PM
Retrophin Q1 2019 Earnings Preview - Seeking AlphaRetrophin Q1 2019 Earnings Preview - Seeking Alpha
seekingalpha.com - May 6 at 7:12 PM
Analysts Estimate Retrophin (RTRX) to Report a Decline in Earnings: What to Look Out for - Yahoo FinanceAnalysts Estimate Retrophin (RTRX) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
finance.yahoo.com - May 1 at 8:47 AM
2 Healthcare Stocks With Jaw-Dropping Growth Potential - Motley Fool2 Healthcare Stocks With Jaw-Dropping Growth Potential - Motley Fool
www.fool.com - April 30 at 6:26 PM
Analysts Estimate Retrophin (RTRX) to Report a Decline in Earnings: What to Look Out for - NasdaqAnalysts Estimate Retrophin (RTRX) to Report a Decline in Earnings: What to Look Out for - Nasdaq
www.nasdaq.com - April 30 at 6:26 PM
Analysts Estimate Retrophin (RTRX) to Report a Decline in Earnings: What to Look Out forAnalysts Estimate Retrophin (RTRX) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - April 30 at 6:26 PM
The Retrophin (NASDAQ:RTRX) Share Price Is Up 41% And Shareholders Are Holding On - Yahoo FinanceThe Retrophin (NASDAQ:RTRX) Share Price Is Up 41% And Shareholders Are Holding On - Yahoo Finance
finance.yahoo.com - April 27 at 5:15 PM
The Retrophin (NASDAQ:RTRX) Share Price Is Up 41% And Shareholders Are Holding OnThe Retrophin (NASDAQ:RTRX) Share Price Is Up 41% And Shareholders Are Holding On
finance.yahoo.com - April 26 at 6:32 PM
Pharma bro Martin Shkreli moved from federal prison after claim he was running drug company with banned cellphone - CNBC'Pharma bro' Martin Shkreli moved from federal prison after claim he was running drug company with banned cellphone - CNBC
www.cnbc.com - April 24 at 6:06 PM
Noteworthy Tuesday Option Activity: SRPT, RTRX, PG - NasdaqNoteworthy Tuesday Option Activity: SRPT, RTRX, PG - Nasdaq
www.nasdaq.com - April 23 at 5:57 PM
Retrophin to Report First Quarter 2019 Financial Results - GlobeNewswireRetrophin to Report First Quarter 2019 Financial Results - GlobeNewswire
www.globenewswire.com - April 23 at 5:57 PM
Retrophin to Report First Quarter 2019 Financial ResultsRetrophin to Report First Quarter 2019 Financial Results
finance.yahoo.com - April 23 at 5:57 PM
Benzingas Top Upgrades, Downgrades For April 22, 2019 - BenzingaBenzinga's Top Upgrades, Downgrades For April 22, 2019 - Benzinga
www.benzinga.com - April 22 at 5:52 PM
Form 8-K Retrophin, Inc. For: Apr 19 - StreetInsider.comForm 8-K Retrophin, Inc. For: Apr 19 - StreetInsider.com
www.streetinsider.com - April 19 at 6:36 PM
Global Primary Biliary Cholangitis Treatment Market to surpass US$ 10,820.8 million by 2026 - Coherent Market Insights - GlobeNewswireGlobal Primary Biliary Cholangitis Treatment Market to surpass US$ 10,820.8 million by 2026 - Coherent Market Insights - GlobeNewswire
www.globenewswire.com - March 19 at 9:17 AM
Retrophin (RTRX) Reports Q4 Loss, Misses Revenue EstimatesRetrophin (RTRX) Reports Q4 Loss, Misses Revenue Estimates
finance.yahoo.com - March 14 at 6:50 PM
Retrophin to Present at Upcoming Investor Conferences - NasdaqRetrophin to Present at Upcoming Investor Conferences - Nasdaq
www.nasdaq.com - March 7 at 6:27 PM
Will Retrophin, Inc.’s (NASDAQ:RTRX) Earnings Grow In The Next Couple Of Years?Will Retrophin, Inc.’s (NASDAQ:RTRX) Earnings Grow In The Next Couple Of Years?
finance.yahoo.com - March 7 at 6:27 PM
Retrophin Recognizes Rare Disease Day® 2019 and Honors People Living with Rare Disease and Their CaregiversRetrophin Recognizes Rare Disease Day® 2019 and Honors People Living with Rare Disease and Their Caregivers
finance.yahoo.com - February 28 at 9:02 AM
Edited Transcript of RTRX earnings conference call or presentation 26-Feb-19 9:30pm GMTEdited Transcript of RTRX earnings conference call or presentation 26-Feb-19 9:30pm GMT
finance.yahoo.com - February 27 at 8:56 AM
Retrophin Inc (RTRX) Q4 2018 Earnings Conference Call TranscriptRetrophin Inc (RTRX) Q4 2018 Earnings Conference Call Transcript
www.fool.com - February 26 at 11:32 PM
Retrophin Reports Fourth Quarter and Full Year 2018 Financial ResultsRetrophin Reports Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - February 26 at 6:15 PM
Retrophin Q4 2018 Earnings Preview - Seeking AlphaRetrophin Q4 2018 Earnings Preview - Seeking Alpha
seekingalpha.com - February 25 at 6:38 PM
Retrophin to Present at the 8th Annual SVB Leerink Global Healthcare ConferenceRetrophin to Present at the 8th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 14 at 5:58 PM
Retrophin to Report Fourth Quarter and Full Year 2018 Financial ResultsRetrophin to Report Fourth Quarter and Full Year 2018 Financial Results
finance.yahoo.com - February 12 at 6:12 PM
Ligand (LGND) Beats on Q4 Earnings & Sales, Raises '19 ViewLigand (LGND) Beats on Q4 Earnings & Sales, Raises '19 View
finance.yahoo.com - February 8 at 8:55 AM
Retrophin Provides Corporate Update and 2019 OutlookRetrophin Provides Corporate Update and 2019 Outlook
finance.yahoo.com - January 7 at 8:43 AM
The Daily Biotech Pulse: Novavax Reports Positive Influenza Vaccine Trial Data, Flexion Warns Of Revenue Shortfall, Retrophins New CEOThe Daily Biotech Pulse: Novavax Reports Positive Influenza Vaccine Trial Data, Flexion Warns Of Revenue Shortfall, Retrophin's New CEO
finance.yahoo.com - January 4 at 5:23 PM
New chief at RetrophinNew chief at Retrophin
seekingalpha.com - January 4 at 10:44 AM
This page was last updated on 6/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel